Fate Therapeutics, Inc.

FATE XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

300M

Short interest (May 15)

8.4%

Net Short (Jun 03 ): -0.2%

Borrow Fee

0.62%

↑ 20.0%

Available Shares

↓ 24.7%

Price Chart

Company Overview

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001434316

Asset Type: CS

Market Data

Market Cap: $299,557,108

Employees: 161

Status: Active

Short Interest

Current Borrow Fee 0.62%

Range: 0.62% - 0.79%

Available Shares 3M

Range: 2.8M - 3.3M

Recent Changes

Fee Change: ↑ 68.6%

Available Change: ↓ 7.8%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime